Molly Pombo

University of Massachusetts Boston

Papers

1

Total Citations

1

H-Index

1

About

Molly Pombo is a rising biomedical researcher whose work focuses on advancing drug delivery systems to improve the bioavailability of macromolecules—a critical challenge in treating chronic diseases. Her most-cited paper, "Enhanced macromolecule bioavailability in rats and pigs using an in situ forming synthetic epithelial lining" (2025), introduces an innovative approach that creates a temporary, synthetic barrier in the gastrointestinal tract to protect therapeutic proteins and peptides from degradation. This breakthrough has the potential to transform oral delivery of biologics, reducing the need for injections and enhancing patient compliance. Although early in her career, Pombo’s work has already garnered attention, with her primary study cited once and recognized for its translational promise in large animal models. Her research bridges materials science and pharmacology, offering a scalable solution for delivering complex drugs like insulin or monoclonal antibodies. Pombo’s contributions are particularly notable for their focus on practical, in vivo validation, setting the stage for future clinical applications. As she continues to explore synthetic epithelial technologies, Pombo is poised to make lasting impacts on how macromolecule-based therapies are administered globally.

Research Focus

Key Achievements

1
H-Index
1
Papers
1
Total Citations
1
Avg Citations/Paper
🏆 Most Cited Paper
Enhanced macromolecule bioavailability in rats and pigs using an in situ forming synthetic epithelial lining
1 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 24
🏛 Institutions: University of Massachusetts Boston

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago